Home / Inspections / 1162064

FDA Inspection 1162064 — Grifols Diagnostic Solutions, Inc.

Grifols Diagnostic Solutions, Inc. — FEI 1000124057

The FDA completed an inspection of Grifols Diagnostic Solutions, Inc. on December 7, 2021 in Emeryville, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 7, 2021
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Emeryville, CA (United States)

Facility

Other inspections at this facility

  • 1289592 (VAI Fri Oct 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1258104 (VAI Fri Dec 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079880 (VAI Fri Feb 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 991586 (VAI Wed Sep 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 894326 (NAI Wed Jan 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources